Mealey's (September 12, 2022, 2:19 PM EDT) -- PHILADELPHIA — The Third Circuit U.S. Court of Appeals on Sept. 7 affirmed dismissal of an amiodarone class action, agreeing that the plaintiffs failed to adequately plead that defendant Teva Pharmaceuticals USA Inc. failed to provide required medication guides, failed to tell the Food and Drug Administration about serious adverse events and enabled the off-label prescribing of the heart drug....